Mochida Pharmaceutical Co. Ltd. engages in the research, development, manufacturing and sale of pharmaceuticals, healthcare products, and medical equipment. The company is headquartered in Shinjuku, Tokyo-To and currently employs 1,508 full-time employees. The Pharmaceutical-related segment is engaged in the manufacture, purchase and sale of pharmaceutical products. The firm also conducts brokerage and management of real estate properties, the maintenance and management of buildings, the agency of personal affairs, accounting and purchasing businesses. The Healthcare segment is involved in the manufacture, purchase and sale of quasi drugs and cosmetic products.
Based on comprehensive analyst evaluations, we have synthesized critical insights from expert assessments to outline a cautious outlook for MCPMF. Analysts note deteriorating fundamentals and challenging market sentiment, indicating potential downside risks in the near term. Following this expert analysis, we adopt a bearish stance on this stock. Our conclusion: MCPMF is a Sell candidate.
MCPMF stock price ended at $9.6 on 星期一, after rising 0.00%
On the latest trading day Jan 26, 2026, the stock price of MCPMF rose by 0.00%, climbing from $0.00 to $9.60. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $0.00 and a high of $0.00. Notably, trading volume dropped by -- shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of -- shares were traded, equating to a market value of approximately $349.3M.